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osting by EAbstract We report the clinical presentation of a 10 month-old infant who succumbed with acute
myocarditis and fulminant hepatic failure associated with a virologically conﬁrmed human inﬂu-
enza A, H1N1 (2009) virus infection. To date, this is the ﬁrst pediatric patient presenting with this
fatal combination of complications during the current H1N1 pandemic. Therefore, we recommend
meticulous assessment and follow up of the cardiac status, liver enzymes and coagulation proﬁle in
all pediatric patients with severe H1N1 inﬂuenza infection.
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The human inﬂuenza A, H1N1 (2009) virus pandemic has seri-
ously hit numerous countries all over the world, including
Egypt. Cases started to be reported in Egypt in June 2009,
peaked in December 2009 and started to decline by April
2010. As of September 2nd, 2010, the total number of con-133705; fax: +20 2 37619012.
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lsevierﬁrmed cases in Egypt was 16,373 (including 5675 school chil-
dren) with 281 deaths [1]. The total population of Egypt is
almost 85,800,000.
The multi-organ distribution of H1N1 virus is unknown
and the ability to spread to multiple organs may be a more
common property of inﬂuenza viruses in mammalian hosts
than previously believed [2]. Studies in mouse models suggest
a more common multiple organ localization than previously
believed, including the lung, heart, thymus, liver and spleen
[2]. Researchers from Rady Children’s Hospital in San Diego,
CA, United States, have recently published the ﬁrst known re-
port of acute myocarditis in a pediatric population associated
with the present pandemic H1N1 inﬂuenza A virus infection
[3]. Researchers from the Universitat de Barcelona, Barcelona,
Spain have published novel inﬂuenza A (H1N1) encephalitis in
a 3-month-old infant [4].
Case report
Our case was a 10 month old male infant, a second sib of non-
consanguineous healthy Egyptian parents, who was admitted
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general pediatric ward, on the 25th December, with high fever
reaching up to 39 C, cough and grade III respiratory distress
of 3 day-duration.
Two previous hospital admissions with respiratory distress
at the age of 3 and 5 months at a local hospital outside Cairo
were diagnosed as bronchopneumonia. During the second
admission echocardiography revealed a previously undiag-
nosed moderate-sized patent ductus arteriosus (PDA), 0.4 cm
pulmonary end with left to right shunt, maximum pressure
gradient across 55–60 mmHg, pulmonary artery systolic pres-
sure 35 mmHg and fractional shortening (FS) 40% (Fig. 1).
Accordingly, he was commenced on oral Frusemide and Cap-
topril; and surgical closure of the ductus was contemplated.
On admission to our hospital, the infant was diagnosed as
having bronchopneumonia with heart failure attributed to
the PDA. He was started on intravenous (IV) antibiotics
(Ampicillin/Sulbactam plus Cefotaxime), IV Frusemide and
oral Captopril and after 48 h, he improved clinically with de-
creased respiratory distress and fever. However, 5 days later,
he spiked fever again up to 40 C and had an attack of hema-Fig. 1 Eechocardiography revealing a previously undiagnosed mode
with left to right shunt, maximum pressure gradient across 55–60 mm
shortening (FS) 40%.temesis followed by drowsiness, cyanosis, hypotension and se-
vere bronchospasm. An endotracheal tube was urgently
placed, and he was rushed to the pediatric intensive care unit
(PICU).
On PICU admission, the infant was tachypneic, stuporous,
with spontaneous eye opening and ﬂexion withdrawal to pain.
There was a picture of bronchopneumonia suggested by chest
examination revealing bilateral diminished air entry with
extensive ﬁne crepitations and wheezes and conﬁrmed by chest
X-ray revealing picture of bilateral bronchopneumonia and
cardiomegaly (Fig. 2). Moreover, he had a picture of myocar-
dial decompensation suggested by severe tachycardia, hypo-
tension and an enlarged tender liver. Liver insult was also
suspected as the patient was icteric with bleeding tendency
(hematemesis and puncture sites). Cranial ultra-sonographic
scan was normal, whereas an abdominal scan revealed moder-
ate hepatomegaly with a homogenous liver echo pattern,
markedly congested hepatic veins and a moderate amount of
clear, free ascitic ﬂuid.
He was put on full mechanical ventilation and was started
on inotropes (Dopamine 8 mcg/kg/min and Dobutaminerate-sized patent ductus arteriosus (PDA), 0.4 cm pulmonary end
Hg, pulmonary artery systolic pressure 35 mmHg and fractional
Fig. 2 Plain chest X-ray revealing a picture of bilateral bron-
chopneumonia and cardiac enlargement.
Acute myocarditis and fulminant hepatic H1N1 infection 19315 mcg/kg/min). In the PICU, the patient had a second attack
of hematemesis and developed poor peripheral perfusion.
Stomach wash with cold saline, vitamin K, H2 blocker (Zan-
tac) and proton-pump inhibitor (Lozec) were added. Repeated
plasma and blood transfusions were received with correction
of the coagulopathy and stoppage of the hematemesis. IV
Amikacin, oral Diﬂucan and inhaled Gentamicin were also
added.
Laboratory investigations revealed markedly elevated liver
enzymes [aspartate amino-transferase (AST) and alanine ami-
no-transferase (ALT)], low serum albumin and prolonged
international normalized ratio (INR) as seen in Table 1. Hep-
atitis A and B virus serological markers were negative. Blood
ammonia was modestly elevated. IV vitamin K1, oral lactulose,
oral Neomycin and repeated enemas were added. When those
laboratory ﬁndings and this clinical picture were associated
with a negative C-reactive protein, it suggested a viral infec-
tion. A bedside echocardiographic examination in the PICU
was compatible with a ‘‘viral myocarditis’’ with a very poor
myocardial contractility and FS of 19% and conﬁrmed the
presence of a hemodynamically signiﬁcant PDA of 5.5 mm
diameter. Cardiac Troponin I and T were normal while MB
fraction of creatine phosphokinase (CPK-MB) was elevated,
possible due to the 2–3 h lag for Troponins to start serum ele-
vations after CPK-MB starts its elevation. Therefore, the pa-
tient received intravenous immunoglobulins 5 g on the ﬁrst
day (700 mg/kg) due to availability in the emergency phar-
macy, to be completed over another 2 days. But, with partial
improvement noticed, another 2 days were added. The pan-
demic H1N1 inﬂuenza A virus was then suspected. The infant
was started on Oseltamavir (2 mg/kg body weight every 12 h)
on the second day of PICU admission. As practiced all over
Egypt (http://www.mohp.gov.eg/swine_ﬂu/news_details.asp-
x?id=76&p=0), a nasal swab for human inﬂuenza A, H1N1(2009) virus was sent to the Egyptian Ministry of Health and
Population Central Laboratories and real time reverse tran-
scription polymerase chain reaction (RT-PCR) was positive
for the virus. Sputum cultures revealed inhibited growth of
normal bacterial ﬂora and blood cultures showed no growth
of aerobic or anaerobic bacteria.
The patient improved clinically after commencing Oseltam-
avir therapy manifested by improved conscious level, cardiac
and chest conditions. This was noticed by better response to
the inotropes in the form of maintained average blood pressure
and peripheral perfusion, and better arterial blood gases with
tendency to decrease the ventilatory settings. Biochemically,
AST, ALT and INR decreased. It was then decided to main-
tain him for 10 days on Oseltamavir.
On day eight of Oseltamavir therapy, the patient deterio-
rated with severe hypoxemia due to bronchospasm necessitating
increased ventilatory settings. He developed bilious vomiting,
repeated attacks of convulsions and massive pulmonary hemor-
rhage. AST and ALT resurged and serum bilirubin increased.
Renal functions also showed an acute kidney injury. Antibiotics
were changed to Imepinem and Metronidazole in a trial to be
more aggressively covering the possible nosocomial infections
acquired in the PICU. He developed cardio-respiratory arrest
with no response to resuscitation and died on the 10th day of
PICU admission.Discussion
It is now clear that, most unusually, healthy children and
young adults are disproportionately affected among those with
severe respiratory disease without underlying conditions due to
H1N1 2009 inﬂuenza virus infection [5]. Children with an
underlying co-morbid disease (such as big PDA in our case)
represent a particular risk group when they contract H1N1
virus infection. Pandemic H1N1 2009 inﬂuenza has been re-
ported to be associated with pediatric death rates 10 times
the rates for seasonal inﬂuenza in previous years and most
deaths were caused by refractory hypoxemia in infants less
than 1 year of age [6]. Our patient was carefully maintained
during his PICU admission on normal or near normal pO2.
The presence of a PDA in our case was an added risk factor.
The initial improvement in a general ward might have given
a false impression of starting cure until H1N1 infection was
well advanced. Our infant was transferred to the PICU with
multiple complications and when Oseltamavir therapy was
commenced, it was probably late in the course of H1N1 infec-
tion. A secondary bacterial infection may also explain the dete-
rioration that occurred, but since he was on antibiotics blood
culture was not beneﬁcial. Because of the very bad general con-
dition of our patient and the instability of his condition, we
were not able to do any invasive procedures such as liver or
endomyocardial biopsies. To the best of our knowledge, our
case is the ﬁrst pediatric H1N1 inﬂuenza infection that pre-
sented with a fatal combination of the recently reported myo-
carditis [3] and the un-reported fulminant hepatic failure.
Therefore, during the current H1N1 pandemic, we recommend
meticulous assessment and follow up of the cardiac status, liver
enzymes and coagulation proﬁle in pediatric cases with severe
H1N1 inﬂuenza infection.
Table 1 Laboratory investigations arranged according to hospital days.
Parameters Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 Day 8 Day 9 Day 10 Day 11 Day 12
WBC (103/mm3) 23 9.8 10.3 15.7 12.8 8.6 15.7
RBC (106/mm3) 3.2 3.66 3.56 4.73 3.9 2.7 4.29
HGB (g/dl) 6.6 7.4 6.9 11.2 9.3 5.4 11.4
HCT (%) 19.7 23.4 24.8 34.9 29.5 18.6 32.5
MCV (lm3) 60.7 63.8 69.7 73.8 75.4 69 75.7
MCH (pg) 20.3 20.1 19.4 23.7 23.8 19.8 26.6
MCHC (g/dl) 33.5 31.5 27.8 32.1 31.5 28.8 35.1
PLT (103/mm3) 259 229 144 116 50 115 91
B (%) 0
E (%) 2
ST (%) 3
SEG (%) 60
LYMPH (%) 30
M (%) 5
ESR= 1st hour 25
ESR= 2nd hour 45
TBIL (mg/dl) 1.2 5.66 7.4
DBIL (mg/dl) 0.9 3.79 4.4
AST (U/l) 4052 699 1029 232 333 449 365 425
ALT (U/l) 1253 1306 1055 130 200 359 325 268
ALB (g/dl) 2.9 3.0 2.7 3.3 2.3 2.7 3.2
TP (g/dl) 6.2 5.8 6
BUN (mg/dl) 48 39 36 34 39 98.2 117 110 128
CRE (mg/dl) 0.7 0.9 0.8 0.8 0.4 1.4 1.1 1.1 1.1
CHOL (mg/dl) 173 164
NA (mmol/l) 148 147 148.6 146 138 144 136.7 140 146
K (mmol/l) 2.8 2.5 3.18 3.38 3.8 4.8 5.34 4.15
PHOS (mg/dl) 3.9 3.8
CA (mg/dl) 8.8 9.9 9.3
ALP (U/l) 59
GLU (mg/dl) 179 128 112 94
GGT (U/l) 55 59
PT (s) 29.6 21.2 16.5
PTT (s) 63 30.9 24.7
PC (%) 25.1 44 65
INR (%) 2.85 1.87 1.36
CRP ve ve ve
pH 7.15 7.4 7.6 7.34
pCO2 56 43 37 51
pO2 165 67 44 38
HCO3 19.5 32.2 38 28.2
Key of abbreviations by order: WBC, white blood cell; RBC, red blood cell; HGB, hemoglobin; HCT, hematocrit; MCV, mean corpuscular
volume; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration; PLT, platelets; B, basophils; E, eosin-
ophils; ST, staff; SEG, segmented; LYMPH, lymphocytes; M, monocytes; ESR, erythrocyte sedimentation rate; TBIL, total bilirubin; DBIL,
direct bilirubin; AST, aspartate amino-transferase; ALT, alanine amino-transferase; ALB, albumin; TP, total protein; BUN, blood urea
nitrogen; CRE, creatinine; CHOL, cholesterol; NA, sodium; K, potassium; PHOS, phosphorus; CA, calcium; ALP, alkaline phosphatase; GLU,
glucose; GGT, gama glutamyl transferase; PT, prothrombin time; PTT, partial thromboplastin time; PC, prothrombin concentration; INR,
international normalized ratio; CRP, c-reactive protein.
Day 1: 31/12/2009; Day 12: 11/1/2010.
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